ZKIN vs CR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 02, 2026

ZKIN

35.7
AI Score
VS
CR Wins

CR

53.6
AI Score

Investment Advisor Scores

ZKIN

36score
Recommendation
SELL

CR

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZKIN CR Winner
Revenue 71.24M 2.31B CR
Net Income -3.99M 366.60M CR
Net Margin -5.6% 15.9% CR
Operating Income -4.25M 424.20M CR
ROE -16.3% 17.8% CR
ROA -6.3% 9.5% CR
Total Assets 62.87M 3.85B CR
Cash 2.31M 506.50M CR
Current Ratio 1.44 5.53 CR

Relative Price Performance (Last 90 Days)

ZKIN 1M: +3.3% · 3M: -7.5% CR 1M: -8.8% · 3M: +7.2%

Current Technical Phase

ZKIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 55.7 · Price: $1.24

CR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.3 · Price: $200.01

Fundamentals Snapshot

Metric ZKIN CR
Market Cap
Forward P/E 0.0 25.6
Trailing P/E 36.1
Revenue (TTM)
Revenue Growth -0.4% 0.3%
Gross Margin 0.1% 0.5%
Operating Margin -8.0% 0.4%
EPS -1.54 5.68
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, CR is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.